Trial
NCT05393089
Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Allergan
Collaborators
—
Condition
Presbyopia
Intervention
AGN-190584
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-29